CytomX Therapeutics, Inc. (CTMX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
CytomX Therapeutics, Inc. (CTMX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $609.5M, listed on NASDAQ, employing roughly 119 people, carrying a beta of 2.17 to the broader market. CytomX Therapeutics, Inc. Led by Sean A. McCarthy, public since 2015-10-08.
Snapshot as of May 15, 2026.
- Spot Price
- $3.63
- Total OI
- 52.4K